- Home
- ONC vs IX Comparison
ONC vs IX Comparison
Compare ONC & IX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- IX
- Stock Information
- Founded
- ONC 2010
- IX 1950
- Country
- ONC Switzerland
- IX Japan
- Employees
- ONC N/A
- IX N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- IX Diversified Financial Services
- Sector
- ONC Health Care
- IX Finance
- Exchange
- ONC Nasdaq
- IX Nasdaq
- Market Cap
- ONC 26.9B
- IX 22.7B
- IPO Year
- ONC N/A
- IX 1970
- Fundamental
- Price
- ONC $247.08
- IX $21.23
- Analyst Decision
- ONC Strong Buy
- IX
- Analyst Count
- ONC 7
- IX 0
- Target Price
- ONC $326.43
- IX N/A
- AVG Volume (30 Days)
- ONC 314.8K
- IX 196.3K
- Earning Date
- ONC 08-06-2025
- IX 08-04-2025
- Dividend Yield
- ONC N/A
- IX 3.05%
- EPS Growth
- ONC N/A
- IX 3.06
- EPS
- ONC N/A
- IX 2.05
- Revenue
- ONC $4,175,868,000.00
- IX $19,197,726,908.00
- Revenue This Year
- ONC $869.15
- IX $8.27
- Revenue Next Year
- ONC $19.07
- IX $5.04
- P/E Ratio
- ONC N/A
- IX $10.12
- Revenue Growth
- ONC 51.16
- IX 2.15
- 52 Week Low
- ONC $141.31
- IX $17.75
- 52 Week High
- ONC $287.88
- IX $25.17
- Technical
- Relative Strength Index (RSI)
- ONC N/A
- IX 52.60
- Support Level
- ONC N/A
- IX $21.14
- Resistance Level
- ONC N/A
- IX $21.42
- Average True Range (ATR)
- ONC 0.00
- IX 0.16
- MACD
- ONC 0.00
- IX -0.06
- Stochastic Oscillator
- ONC 0.00
- IX 20.73
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
About IX Orix Corp Ads
ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.